XPERI INC (XPER) Fundamental Analysis & Valuation

NYSE:XPER • US98423J1016

Current stock price

5.79 USD
+0.14 (+2.48%)
At close:
5.79 USD
0 (0%)
After Hours:

This XPER fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. XPER Profitability Analysis

1.1 Basic Checks

  • XPER had positive earnings in the past year.
  • In the past year XPER has reported a negative cash flow from operations.
  • XPER had negative earnings in each of the past 5 years.
  • In the past 5 years XPER reported 4 times negative operating cash flow.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -9.15%, XPER is doing worse than 61.15% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -13.61%, XPER is in line with its industry, outperforming 44.24% of the companies in the same industry.
Industry RankSector Rank
ROA -9.15%
ROE -13.61%
ROIC N/A
ROA(3y)-10.51%
ROA(5y)-29.72%
ROE(3y)-16.89%
ROE(5y)-46.25%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • XPER's Gross Margin of 71.74% is in line compared to the rest of the industry. XPER outperforms 57.55% of its industry peers.
  • XPER's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for XPER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-1.99%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. XPER Health Analysis

2.1 Basic Checks

  • XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XPER has more shares outstanding than it did 1 year ago.
  • XPER has more shares outstanding than it did 5 years ago.
  • XPER has a better debt/assets ratio than last year.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -0.45, we must say that XPER is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of XPER (-0.45) is worse than 72.66% of its industry peers.
  • XPER has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • XPER has a Debt to Equity ratio (0.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACCN/A
WACC10.78%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.42 indicates that XPER has no problem at all paying its short term obligations.
  • The Current ratio of XPER (2.42) is better than 66.91% of its industry peers.
  • XPER has a Quick Ratio of 2.42. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 2.42, XPER is doing good in the industry, outperforming 67.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.42
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. XPER Growth Analysis

3.1 Past

  • XPER shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.56%.
  • The earnings per share for XPER have been decreasing by -26.53% on average. This is quite bad
  • XPER shows a decrease in Revenue. In the last year, the revenue decreased by -9.23%.
  • XPER shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.57% yearly.
EPS 1Y (TTM)-18.56%
EPS 3YN/A
EPS 5Y-26.53%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)-9.23%
Revenue growth 3Y-3.73%
Revenue growth 5Y3.57%
Sales Q2Q%-4.78%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.25% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.64% on average over the next years. This is quite good.
EPS Next Y26.37%
EPS Next 2Y25.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.55%
Revenue Next 2Y5.29%
Revenue Next 3Y11.61%
Revenue Next 5Y11.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. XPER Valuation Analysis

4.1 Price/Earnings Ratio

  • XPER is valuated cheaply with a Price/Earnings ratio of 7.33.
  • 92.81% of the companies in the same industry are more expensive than XPER, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, XPER is valued rather cheaply.
  • The Price/Forward Earnings ratio is 5.80, which indicates a rather cheap valuation of XPER.
  • 91.73% of the companies in the same industry are more expensive than XPER, based on the Price/Forward Earnings ratio.
  • XPER is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.33
Fwd PE 5.8
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • XPER's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • XPER's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XPER's earnings are expected to grow with 25.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y25.25%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XPER Dividend Analysis

5.1 Amount

  • XPER does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XPER Fundamentals: All Metrics, Ratios and Statistics

XPERI INC

NYSE:XPER (3/23/2026, 4:52:11 PM)

After market: 5.79 0 (0%)

5.79

+0.14 (+2.48%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners90.97%
Inst Owner Change0.02%
Ins Owners2.97%
Ins Owner Change9.23%
Market Cap271.96M
Revenue(TTM)448.11M
Net Income(TTM)-56.34M
Analysts81.82
Price Target11.63 (100.86%)
Short Float %7.47%
Short Ratio7.78
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.89%
Min EPS beat(2)8.43%
Max EPS beat(2)31.34%
EPS beat(4)4
Avg EPS beat(4)166.68%
Min EPS beat(4)8.43%
Max EPS beat(4)613.01%
EPS beat(8)8
Avg EPS beat(8)179.25%
EPS beat(12)12
Avg EPS beat(12)142.38%
EPS beat(16)16
Avg EPS beat(16)120.08%
Revenue beat(2)2
Avg Revenue beat(2)0.51%
Min Revenue beat(2)0.19%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)-2.15%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)0.84%
Revenue beat(8)2
Avg Revenue beat(8)-2.54%
Revenue beat(12)2
Avg Revenue beat(12)-2.49%
Revenue beat(16)3
Avg Revenue beat(16)-8.22%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-29.59%
EPS NQ rev (3m)-29.59%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)6.16%
Revenue NQ rev (1m)-4.74%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-2.98%
Revenue NY rev (3m)-2.73%
Valuation
Industry RankSector Rank
PE 7.33
Fwd PE 5.8
P/S 0.61
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB 0.95
EV/EBITDA 46
EPS(TTM)0.79
EY13.64%
EPS(NY)1
Fwd EY17.24%
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS9.54
BVpS8.82
TBVpS6.07
PEG (NY)0.28
PEG (5Y)N/A
Graham Number12.52
Profitability
Industry RankSector Rank
ROA -9.15%
ROE -13.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.74%
FCFM N/A
ROA(3y)-10.51%
ROA(5y)-29.72%
ROE(3y)-16.89%
ROE(5y)-46.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.7%
GM growth 5Y-1.99%
F-Score2
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 8.82
Cap/Depr 43.48%
Cap/Sales 4.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2.42
Altman-Z -0.45
F-Score2
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)30.38%
Cap/Depr(5y)23.12%
Cap/Sales(3y)3.53%
Cap/Sales(5y)3.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.56%
EPS 3YN/A
EPS 5Y-26.53%
EPS Q2Q%-38.46%
EPS Next Y26.37%
EPS Next 2Y25.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.23%
Revenue growth 3Y-3.73%
Revenue growth 5Y3.57%
Sales Q2Q%-4.78%
Revenue Next Year2.55%
Revenue Next 2Y5.29%
Revenue Next 3Y11.61%
Revenue Next 5Y11.64%
EBIT growth 1Y48.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.95%
EBIT Next 3Y42.18%
EBIT Next 5Y30.81%
FCF growth 1Y70.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.07%
OCF growth 3YN/A
OCF growth 5YN/A

XPERI INC / XPER Fundamental Analysis FAQ

What is the fundamental rating for XPER stock?

ChartMill assigns a fundamental rating of 4 / 10 to XPER.


What is the valuation status of XPERI INC (XPER) stock?

ChartMill assigns a valuation rating of 7 / 10 to XPERI INC (XPER). This can be considered as Undervalued.


What is the profitability of XPER stock?

XPERI INC (XPER) has a profitability rating of 1 / 10.


How financially healthy is XPERI INC?

The financial health rating of XPERI INC (XPER) is 4 / 10.


Is the dividend of XPERI INC sustainable?

The dividend rating of XPERI INC (XPER) is 0 / 10 and the dividend payout ratio is 0%.